secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001638833-24-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q4 revenue +4% to $735.4M; FY Adjusted EBITDA $438.1M; guides 2024 revenue >$3B
--------------------------------------------------------------------------------

- Q4 revenue $735.4M (+4.0% YoY); full-year revenue $2.74B (+8.0% YoY).
- Q4 Adjusted EBITDA $142.3M (+17.8% YoY); FY Adjusted EBITDA $438.1M (+15.2% YoY).
- Days adjusted same-facility revenue +8.1% Q4, +11.3% full year vs 2022.
- Net loss attributable to common: $1.0M Q4, $11.9M full year 2023.
- 2024 guidance: revenue >$3.0B, Adjusted EBITDA >$495M; liquidity ~$900M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000026/0001638833-24-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000026/sgry-20240226.htm
  HTML page:      https://secwatch.observer/filing/0001638833-24-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer